These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 19052708)

  • 21. Use of methylnaltrexone to induce laxation in acutely injured patients with burns and necrotizing soft-tissue infections.
    Hewitt K; Lin H; Faraklas I; Morris S; Cochran A; Saffle J
    J Burn Care Res; 2014; 35(2):e106-11. PubMed ID: 23877147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opioid side effects--mechanism-based therapy.
    Berde C; Nurko S
    N Engl J Med; 2008 May; 358(22):2400-2. PubMed ID: 18509126
    [No Abstract]   [Full Text] [Related]  

  • 23. Novel Oral Therapies for Opioid-induced Bowel Dysfunction in Patients with Chronic Noncancer Pain.
    Holder RM; Rhee D
    Pharmacotherapy; 2016 Mar; 36(3):287-99. PubMed ID: 26945548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overview and treatment of opioid-induced constipation.
    McCarberg BH
    Postgrad Med; 2013 Jul; 125(4):7-17. PubMed ID: 23782897
    [No Abstract]   [Full Text] [Related]  

  • 25. Optimal treatment of opioid induced constipation in daily clinical practice - an observational study.
    Neefjes ECW; van der Wijngaart H; van der Vorst MJDL; Ten Oever D; van der Vliet HJ; Beeker A; Rhodius CA; van den Berg HP; Berkhof J; Verheul HMW
    BMC Palliat Care; 2019 Mar; 18(1):31. PubMed ID: 30922276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Naloxegol: A Novel Therapy in the Management of Opioid-Induced Constipation.
    Jones R; Prommer E; Backstedt D
    Am J Hosp Palliat Care; 2016 Nov; 33(9):875-880. PubMed ID: 26150678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subsidised use of methylnaltrexone in Australia for palliative care.
    Rowett DS; Clark K; Robinson MK; Currow DC
    Med J Aust; 2012 Nov; 197(9):492. PubMed ID: 23121581
    [No Abstract]   [Full Text] [Related]  

  • 28. Current concepts in the management of opioid-induced constipation.
    Walters JB; Montagnini M
    J Opioid Manag; 2010; 6(6):435-44. PubMed ID: 21269005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylnaltrexone for opioid-induced constipation in pediatric oncology patients.
    Rodrigues A; Wong C; Mattiussi A; Alexander S; Lau E; Dupuis LL
    Pediatr Blood Cancer; 2013 Oct; 60(10):1667-70. PubMed ID: 23766091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective study of methylnaltrexone for opioid-induced constipation in advanced illness: should we use it or not?
    Centeno C; Carranza O; Zuriarrain Y; Portela MA; Larumbe A; Canal J; Palomar C
    J Pain Symptom Manage; 2013 Nov; 46(5):e1-3. PubMed ID: 24176612
    [No Abstract]   [Full Text] [Related]  

  • 31. Opioids and opioid receptors in the enteric nervous system: from a problem in opioid analgesia to a possible new prokinetic therapy in humans.
    Holzer P
    Neurosci Lett; 2004 May; 361(1-3):192-5. PubMed ID: 15135926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence, prevalence, and management of opioid bowel dysfunction.
    Pappagallo M
    Am J Surg; 2001 Nov; 182(5A Suppl):11S-18S. PubMed ID: 11755892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Is the pharmacological treatment of constipation in palliative care evidence based? : a systematic literature review].
    Bader S; Weber M; Becker G
    Schmerz; 2012 Sep; 26(5):568-86. PubMed ID: 23052993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An update on the use of pharmacotherapy for opioid-induced bowel dysfunction.
    Mousavi T; Nikfar S; Abdollahi M
    Expert Opin Pharmacother; 2023 Feb; 24(3):359-375. PubMed ID: 36548911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylnaltrexone bromide for the treatment of opioid-induced constipation in patients with advanced illness--a cost-effectiveness analysis.
    Earnshaw SR; Klok RM; Iyer S; McDade C
    Aliment Pharmacol Ther; 2010 Apr; 31(8):911-21. PubMed ID: 20096019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical status of methylnaltrexone, a new agent to prevent and manage opioid-induced side effects.
    Yuan CS
    J Support Oncol; 2004; 2(2):111-7; discussion 119-22. PubMed ID: 15328815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of the potential role of methylnaltrexone in opioid bowel dysfunction.
    Foss JF
    Am J Surg; 2001 Nov; 182(5A Suppl):19S-26S. PubMed ID: 11755893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of methylnaltrexone for the treatment of opiod-induced constipation: a meta-analysis and systematic review.
    Mehta N; O'Connell K; Giambrone GP; Baqai A; Diwan S
    Postgrad Med; 2016; 128(3):282-9. PubMed ID: 26839023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treating Opioid-Induced Constipation in Older Adults: New Options.
    Sani H; Mahan RJ
    Consult Pharm; 2015 Oct; 30(10):612-5. PubMed ID: 26450143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opioid-Induced Constipation and Acupuncture: A Case Discussion.
    Olson EA; Metzger AK; Mallory MJ; Mackey RM
    J Pain Symptom Manage; 2021 Oct; 62(4):876-880. PubMed ID: 33556492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.